<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gillespie TC</submitter><funding>NEI NIH HHS</funding><funding>NCATS NIH HHS</funding><pagination>23</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9680586</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>63(12)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>Retinopathy of prematurity (ROP) can lead to blindness. Arachidonic acid (ARA) and docosahexaenoic acid (DHA) regulate retinal inflammation and angiogenesis. The aim of this study was to investigate red blood cell membrane (RBCM) ARA and DHA in preterm infants.&lt;h4>Methods&lt;/h4>This prospective observational study divided infants into groups by ROP severity and RBCM ARA and DHA means and terciles.&lt;h4>Results&lt;/h4>Although the mean ± SD RBCM ARA was different between groups (no ROP, 17.9% ± 0.7%, vs. type 2 ROP, 17.4% ± 0.8%, vs. type 1 ROP, 16.7% ± 1.0%; P &lt; 0.001), the mean RBCM DHA was similar (P = 0.161). Infants with type 1 ROP were more likely to be in the lowest ARA and DHA terciles than in the highest (ARA, 44% vs. 5.6%; DHA, 22% vs. 5.6%). ARA and DHA declined over the</pubmed_abstract><journal>Investigative ophthalmology &amp; visual science</journal><pubmed_title>Decreased Levels of Erythrocyte Membrane Arachidonic and Docosahexaenoic Acids Are Associated With Retinopathy of Prematurity.</pubmed_title><pmcid>PMC9680586</pmcid><funding_grant_id>KL2 TR000122</funding_grant_id><funding_grant_id>UL1 TR001881</funding_grant_id><funding_grant_id>T32 EY007026</funding_grant_id><funding_grant_id>R01 EY032561</funding_grant_id><pubmed_authors>Chu A</pubmed_authors><pubmed_authors>Calkins KL</pubmed_authors><pubmed_authors>Gillespie TC</pubmed_authors><pubmed_authors>Grogan T</pubmed_authors><pubmed_authors>Kim ES</pubmed_authors><pubmed_authors>Tsui I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Decreased Levels of Erythrocyte Membrane Arachidonic and Docosahexaenoic Acids Are Associated With Retinopathy of Prematurity.</name><description>&lt;h4>Purpose&lt;/h4>Retinopathy of prematurity (ROP) can lead to blindness. Arachidonic acid (ARA) and docosahexaenoic acid (DHA) regulate retinal inflammation and angiogenesis. The aim of this study was to investigate red blood cell membrane (RBCM) ARA and DHA in preterm infants.&lt;h4>Methods&lt;/h4>This prospective observational study divided infants into groups by ROP severity and RBCM ARA and DHA means and terciles.&lt;h4>Results&lt;/h4>Although the mean ± SD RBCM ARA was different between groups (no ROP, 17.9% ± 0.7%, vs. type 2 ROP, 17.4% ± 0.8%, vs. type 1 ROP, 16.7% ± 1.0%; P &lt; 0.001), the mean RBCM DHA was similar (P = 0.161). Infants with type 1 ROP were more likely to be in the lowest ARA and DHA terciles than in the highest (ARA, 44% vs. 5.6%; DHA, 22% vs. 5.6%). ARA and DHA declined over the</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-25T19:59:24.245Z</modification><creation>2025-04-06T08:11:39.713Z</creation></dates><accession>S-EPMC9680586</accession><cross_references><pubmed>36383353</pubmed><doi>10.1167/iovs.63.12.23</doi></cross_references></HashMap>